Skip to main content
. Author manuscript; available in PMC: 2009 Aug 13.
Published in final edited form as: J Neuroimmunol. 2008 Jun 27;199(1-2):75–82. doi: 10.1016/j.jneuroim.2008.05.009

Figure 5. Pre-treatment with Pam3CSK4 prevented the decrease in Occludin following cerebral I/R.

Figure 5

Cellular proteins were isolated from brain tissues of sham (S), cerebral I/R (I/R), Pam3SCK4 treated sham control (Pam-S), and Pam3SCK4 treated I/R (Pam-I/R) mice, respectively and subjected to Western blot with specific antibody against Occludin. The data are expressed as mean ± standard error (s.e.). *compared with sham, p<0.05; #compared with I/R, p<0.05.